Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Silver Nanoparticles for Microbial Activity
NCT03752424Phase 1Unknown
- Start
- Nov 2019
- Primary completion
- Jan 2020
- Modality
- Nanoparticles, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 1, open-label trial of silver nanoparticles in tinea pedis, tinea capitis and tinea versicolor (2 arms). Primary endpoint: Antimicrobial activity of silver nanoparticles at 6 months. Status: unknown.
02
Drugs
silver nanoparticles
03
Conditions
tinea pedistinea capitistinea versicolor
Beyond the preview
Go deeper on NCT03752424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03752424.